Aptar CSP Technologies announced its Activ-Film technology protects two new at-home COVID-19 tests that recently received Emergency Use Authorization (EUA) from the U.S. FDA. The tests were developed by a leading manufacturer of diagnostic healthcare solutions and offer prescription and OTC COVID-19 at-home testing options without the need to visit a doctor’s office. Aptar CSP’s Activ-Film technology is integrated into the dipstick of the diagnostic kits to protect against moisture and oth...